Literature DB >> 17504779

Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect.

M Alan Brookhart1, Amanda R Patrick, Colin Dormuth, Jerry Avorn, William Shrank, Suzanne M Cadarette, Daniel H Solomon.   

Abstract

Patients who adhere to preventive therapies may be more likely to engage in a broad spectrum of behaviors consistent with a healthy lifestyle. Because many of these behaviors cannot be measured easily, observational studies of outcomes associated with the long-term use of preventive therapies are subject to the so-called "healthy user bias." To better understand this effect, the authors examined the association between adherence to statin therapy and the use of preventive health services in a Pennsylvania cohort of 20,783 new users of statins between 1996 and 2004. After adjustment for age, gender, and various comorbid conditions, patients who filled two or more prescriptions for a statin during a 1-year ascertainment period were more likely than patients who filled only one prescription to receive prostate-specific antigen tests (hazard ratio (HR)=1.57, 95% confidence interval (CI): 1.17, 2.19), fecal occult blood tests (HR=1.31, 95% CI: 1.12, 1.53), screening mammograms (HR=1.22, 95% CI: 1.09, 1.38), influenza vaccinations (HR=1.21, 95% CI: 1.12, 1.31), and pneumococcal vaccinations (HR=1.46, 95% CI: 1.17, 1.83) during follow-up. These results suggest that patients who adhere to chronic therapies are more likely to seek out preventive health services, such as screening tests and vaccinations. Further work is needed to identify study design and analysis methods that can be used to minimize the healthy user bias in studies of preventive therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17504779     DOI: 10.1093/aje/kwm070

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  161 in total

1.  Trends and Determinants of Osteoporosis Treatment and Screening in Patients With Rheumatoid Arthritis Compared to Osteoarthritis.

Authors:  Gulsen Ozen; Diane L Kamen; Ted R Mikuls; Bryant R England; Frederick Wolfe; Kaleb Michaud
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-03-11       Impact factor: 4.794

2.  Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors.

Authors:  S M Cadarette; D H Solomon; J N Katz; A R Patrick; M A Brookhart
Journal:  Osteoporos Int       Date:  2010-06-08       Impact factor: 4.507

3.  Understanding the potential role of statins in pneumonia and sepsis.

Authors:  Sachin Yende; Eric B Milbrandt; John A Kellum; Lan Kong; Russell L Delude; Lisa A Weissfeld; Derek C Angus
Journal:  Crit Care Med       Date:  2011-08       Impact factor: 7.598

4.  Statins and influenza: can we move forward?

Authors:  Edward E Walsh
Journal:  J Infect Dis       Date:  2011-12-13       Impact factor: 5.226

5.  Methods to examine the impact of compliance to osteoporosis pharmacotherapy on fracture risk: systematic review and recommendations.

Authors:  Milica Nikitovic; Daniel H Solomon; Suzanne M Cadarette
Journal:  Ther Adv Chronic Dis       Date:  2010-11-01       Impact factor: 5.091

6.  Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data.

Authors:  Jeffrey R Curtis; Huifeng Yun; Jeff L Lange; Robert Matthews; Pradeep Sharma; Kenneth G Saag; Elizabeth Delzell
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-12       Impact factor: 4.794

7.  Thiazolidinedione use and ulcerative colitis-related flares: an exploratory analysis of administrative data.

Authors:  Jennifer L Lund; Til Stürmer; Carol Q Porter; Robert S Sandler; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2011-03       Impact factor: 5.325

8.  Leisure-time physical activity, cardiovascular risk factors and mortality during a 34-year follow-up in men.

Authors:  Salla Savela; Pentti Koistinen; Reijo S Tilvis; Arto Y Strandberg; Kaisu H Pitkälä; Veikko V Salomaa; Tatu A Miettinen; Timo E Strandberg
Journal:  Eur J Epidemiol       Date:  2010-06-24       Impact factor: 8.082

9.  Contribution of Breast Cancer to Overall Mortality for US Women.

Authors:  Ronald E Gangnon; Natasha K Stout; Oguzhan Alagoz; John M Hampton; Brian L Sprague; Amy Trentham-Dietz
Journal:  Med Decis Making       Date:  2018-04       Impact factor: 2.583

10.  Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study.

Authors:  Elizabeth Rogawski; Leah McGrath; Nadja Vielot; Daniel Westreich
Journal:  Heart       Date:  2014-01-16       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.